For example, increased expression of TAL1[40], SCG3[41] and GSDMA[42], [43] has been observed in cancers, and somatic mutations in the 3′UTRs of these genes disrupt putative targets of miRNAs that have been associated with cancer. This evidence concerns the gene SCG3 and cancer.